Application of Bronchial Blocker in Minimally Invasive Cardiac Surgery

Minimally Invasive Cardiac Surgery Clinical Trial

Official title:

Bronchial Blocker in Blocking the Right Middle Lower Lobe Versus Double-Lumen Endotracheal Tube for One-Lung Ventilation in Minimally Invasive Cardiac Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03505242
• Other study ID #: ABMICS
• Status: Not yet recruiting
• Phase: N/A
• First received: August 30, 2017
• Last updated: April 12, 2018
• Start date: May 1, 2018
• Est. completion date: May 1, 2020

Study information

• Verified date: April 2018
• Source: Shanghai Zhongshan Hospital
• Contact: Kefang Guo
• Phone: +8613817706936
• Email: guo.kefang[@]zs-hospital.sh.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Both left single lung ventilation by left double lumen tube and bilateral ventilation with selective blockage of right middle lower lobe by bronchial blocker can provide suitable surgical field for minimally invasive cardiac surgery. The current study was designed to compare the impact of these two different methods on oxygenation, degree of pulmonary collapse and postoperative complications.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 48
• Est. completion date: May 1, 2020
• Est. primary completion date: May 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• ASA II-III

• BMI 18-31

• elective minimally invasive cardiac surgery by right thoracotomy

Exclusion Criteria:

• asthma

• COPD

• previous lung surgery

• previous cardiac surgery

Related Conditions & MeSH terms

• Minimally Invasive Cardiac Surgery

Intervention

Device:
• bronchial blocker for BB group
Using bronchial blocker to block right middle lower lobe during surgery.
• double lumen tube for DLT group
Using double lumen tube to achieve single lung ventilation during surgery.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai Zhongshan Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	oxygenation	record SpO2 and PaO2 during selective ventilation	intraoperative
Secondary	degree of pulmonary collapse	surgeon score the degree of pulmonary collapse (1 for no pulmonary collapse and 5 for excellent pulmonary collapse)	intraoperative